Marjon Al - Concepedia

Author

Marjon Al

Also Known As

Marjon Al

Publications

289

Citations

H-Index

Concepts

All Affiliations

Marjon Al is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in autoimmunity, rheumatology, and inflammatory arthritis.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	105
2	Allergy	1	1	105
3	Immunology	1	1	105
4	Pathology	1	1	105
5	Rheumatology	1	1	105

Marjon Al

Publications

271

Citations

H-Index

Page 1

	Year	Citations
Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis Sue Ellen Verbrugge, Yehuda G. Assaraf, Ben A. C. Dijkmans, Journal of Pharmacology and Experimental Therapeutics	2012	107
IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI Esil Aleyd, Marjon Al, Cornelis W. Tuk, The Journal of Immunology ImmunologyPathologyImmune SystemInflammatory ArthritisInflammation	2016	105
Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf, Oncotarget	2015	30
Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf, Experimental Hematology and Oncology	2013	19
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters Noortje van Gils, Han Verhagen, Michaël Broux, iScience	2022	10

Page 1